{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:35:26Z","timestamp":1777160126391,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG049617"],"award-info":[{"award-number":["AG049617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG059418"],"award-info":[{"award-number":["AG059418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011769","name":"Scripps Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cellular senescence plays a significant role in age-related conditions like osteoarthritis (OA) and intervertebral disc degeneration, in part due to the accumulation of senescent cells (SCs) in musculoskeletal tissues. Identifying novel therapeutics that can clear SCs is crucial for improving musculoskeletal health in the elderly. The present study aimed to elucidate the changes in Class I histone deacetylases (HDACs) and their role during senescence. All Class I HDACs except HDAC1 were downregulated during senescence in the human TC28a2 immortalized human chondrocyte cell line. Knockdown experiments showed that HDAC1 is essential for maintaining the viability of both non-senescent cells (NSCs) and SCs, while HDAC2 plays a key role in modulating inflammation in part by targeting the NF-\u03baB signaling pathway. Mocetinostat, an HDAC inhibitor, selectively kills senescent TC28a2 cells and primary human knee chondrocytes via apoptosis while not affecting the viability of NSCs. Mocetinostat also affected both inflammation-associated and chondrogenesis-associated genes. Overall, our findings demonstrate a key role of Class I HDACs in regulating chondrocyte survival and ECM gene expression. Mocetinostat holds promise as a senolytic therapeutic for OA and potentially other aging-related musculoskeletal disorders.<\/jats:p>","DOI":"10.1007\/s11357-026-02260-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:32:17Z","timestamp":1777152737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Class I histone deacetylases and their inhibitors as targets to modulate cellular senescence in osteoarthritis"],"prefix":"10.1007","author":[{"given":"Kavya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Swahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-8799","authenticated-orcid":false,"given":"Martin K.","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"9","key":"2260_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","volume":"21","author":"T Neogi","year":"2013","unstructured":"Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145\u201353.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10182","key":"2260_CR2","first-page":"1745","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis Lancet. 2019;393(10182):1745\u201359.","journal-title":"Osteoarthritis Lancet"},{"key":"2260_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101413","volume":"70","author":"J Xie","year":"2021","unstructured":"Xie J, Wang Y, Lu L, Liu L, Yu X, Pei F. Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications. Ageing Res Rev. 2021;70:101413.","journal-title":"Ageing Res Rev"},{"key":"2260_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X241273009","volume":"16","author":"M Langworthy","year":"2024","unstructured":"Langworthy M, Dasa V, Spitzer AI. Knee osteoarthritis: disease burden, available treatments, and emerging options. Ther Adv Musculoskelet Dis. 2024;16:1759720X241273009.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"2260_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jprot.2011.02.017","volume":"74","author":"AL Clutterbuck","year":"2011","unstructured":"Clutterbuck AL, Smith JR, Allaway D, Harris P, Liddell S, Mobasheri A. High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation. J Proteomics. 2011;74(5):704\u201315.","journal-title":"J Proteomics"},{"issue":"11","key":"2260_CR6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.joca.2015.01.008","volume":"23","author":"MA Greene","year":"2015","unstructured":"Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1966\u201371.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"2260_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/annrheumdis-2014-206295","volume":"75","author":"W Hui","year":"2016","unstructured":"Hui W, Young DA, Rowan AD, Xu X, Cawston TE, Proctor CJ. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann Rheum Dis. 2016;75(2):449\u201358.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2260_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412\u201320.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"2260_CR9","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/art.39073","volume":"67","author":"B Carames","year":"2015","unstructured":"Carames B, Olmer M, Kiosses WB, Lotz MK. The relationship of autophagy defects to cartilage damage during joint aging in a mouse model. Arthritis Rheumatol. 2015;67(6):1568\u201376.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2260_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-020-00533-7","volume":"17","author":"PR Coryell","year":"2021","unstructured":"Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47\u201357.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2260_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-022-02859-x","volume":"24","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang Z, Li T, Xu H, Zhang H. Senescence in osteoarthritis: from mechanism to potential treatment. Arthritis Res Ther. 2022;24(1):174.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2260_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41413-024-00375-z","volume":"12","author":"Z Han","year":"2024","unstructured":"Han Z, Wang K, Ding S, Zhang M. Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis. Bone Res. 2024;12(1):69.","journal-title":"Bone Res"},{"issue":"6","key":"2260_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133(6):1019\u201331.","journal-title":"Cell"},{"issue":"8","key":"2260_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978\u201390.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2260_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024;25(12):958\u201378.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2260_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.201708092","volume":"217","author":"D McHugh","year":"2018","unstructured":"McHugh D, Gil J. Senescence and aging: causes, consequences, and therapeutic avenues. J Cell Biol. 2018;217(1):65\u201377.","journal-title":"J Cell Biol"},{"key":"2260_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00016","volume":"14","author":"C Martinez-Cue","year":"2020","unstructured":"Martinez-Cue C, Rueda N. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci. 2020;14:16.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2260_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41413-021-00164-y","volume":"9","author":"M Wan","year":"2021","unstructured":"Wan M, Gray-Gaillard EF, Elisseeff JH. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res. 2021;9(1):41.","journal-title":"Bone Res"},{"issue":"4","key":"2260_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41569-021-00624-2","volume":"19","author":"M Mehdizadeh","year":"2022","unstructured":"Mehdizadeh M, Aguilar M, Thorin E, Ferbeyre G, Nattel S. The role of cellular senescence in cardiac disease: basic biology and clinical relevance. Nat Rev Cardiol. 2022;19(4):250\u201364.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2260_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s11658-023-00501-5","volume":"28","author":"X He","year":"2023","unstructured":"He X, Hu W, Zhang Y, Chen M, Ding Y, Yang H, et al. Cellular senescence in skeletal disease: mechanisms and treatment. Cell Mol Biol Lett. 2023;28(1):88.","journal-title":"Cell Mol Biol Lett"},{"issue":"6441","key":"2260_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.aaw1299","volume":"364","author":"JM van Deursen","year":"2019","unstructured":"van Deursen JM. Senolytic therapies for healthy longevity. Science. 2019;364(6441):636\u20137.","journal-title":"Science"},{"issue":"5","key":"2260_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518\u201336.","journal-title":"J Intern Med"},{"issue":"6","key":"2260_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2021","unstructured":"Robbins PD, Jurk D, Khosla S, Kirkland JL, LeBrasseur NK, Miller JD, et al. Senolytic drugs: reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol. 2021;61(6):779\u2013803.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"15","key":"2260_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158450","volume":"132","author":"L Zhang","year":"2022","unstructured":"Zhang L, Pitcher LE, Yousefzadeh MJ, Niedernhofer LJ, Robbins PD, Zhu Y. Cellular senescence: a key therapeutic target in aging and diseases. J Clin Invest. 2022;132(15): e158450.","journal-title":"J Clin Invest."},{"key":"2260_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phrs.2017.08.007","volume":"128","author":"NM Khan","year":"2018","unstructured":"Khan NM, Haqqi TM. Epigenetics in osteoarthritis: potential of HDAC inhibitors as therapeutics. Pharmacol Res. 2018;128:73\u20139.","journal-title":"Pharmacol Res"},{"key":"2260_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.intimp.2017.02.009","volume":"45","author":"W Zheng","year":"2017","unstructured":"Zheng W, Feng Z, You S, Zhang H, Tao Z, Wang Q. Fisetin inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. Int Immunopharmacol. 2017;45:135\u201347.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2260_CR27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon OH, Kim C, Laberge RM, Demaria M, Rathod S, Vasserot AP, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775\u201381.","journal-title":"Nat Med"},{"issue":"1","key":"2260_CR28","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/s41598-017-01964-1","volume":"7","author":"L Samaraweera","year":"2017","unstructured":"Samaraweera L, Adomako A, Rodriguez-Gabin A, McDaid HM. A novel indication for panobinostat as a senolytic drug in NSCLC and HNSCC. Sci Rep. 2017;7(1):1900.","journal-title":"Sci Rep"},{"issue":"17","key":"2260_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170513","volume":"8","author":"M Kawata","year":"2023","unstructured":"Kawata M, McClatchy DB, Diedrich JK, Olmer M, Johnson KA, Yates JR, et al. Mocetinostat activates Kruppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis. JCI Insight. 2023;8(17): e170513.","journal-title":"JCI Insight."},{"key":"2260_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev.biochem.70.1.81","volume":"70","author":"SY Roth","year":"2001","unstructured":"Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem. 2001;70:81\u2013120.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"2260_CR31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/cells8091034","volume":"8","author":"AA Igolkina","year":"2019","unstructured":"Igolkina AA, Zinkevich A, Karandasheva KO, Popov AA, Selifanova MV, Nikolaeva D, et al. H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks. Cells. 2019;8(9):1034.","journal-title":"Cells."},{"issue":"14","key":"2260_CR32","doi-asserted-by":"publisher","first-page":"17978","DOI":"10.18632\/aging.203304","volume":"13","author":"C Warnon","year":"2021","unstructured":"Warnon C, Bouhjar K, Ninane N, Verhoyen M, Fattaccioli A, Fransolet M, et al. HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts. Aging (Albany NY). 2021;13(14):17978\u20138005.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2260_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2260_CR34","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.3892\/mmr.2016.5730","volume":"14","author":"K Xu","year":"2016","unstructured":"Xu K, Wang X, Zhang Q, Liang A, Zhu H, Huang D, et al. Sp1 downregulates proinflammatory cytokine\u2011induced catabolic gene expression in nucleus pulposus cells. Mol Med Rep. 2016;14(4):3961\u20138.","journal-title":"Mol Med Rep"},{"issue":"544","key":"2260_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuroscience.2024.02.014","volume":"19","author":"H Guo","year":"2024","unstructured":"Guo H, Du M, Yang Y, Lin X, Wang Y, Li H, et al. Sp1 regulates the M1 polarization of microglia through the HuR\/NF-kappaB axis after spinal cord injury. Neuroscience. 2024;19(544):50\u201363.","journal-title":"Neuroscience"},{"key":"2260_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2260_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1359\/jbmr.2001.16.3.501","volume":"16","author":"KA Roebuck","year":"2001","unstructured":"Roebuck KA, Vermes C, Carpenter LR, Fritz EA, Narayanan R, Glant TT. Down-regulation of procollagen alpha1[I]] messenger RNA by titanium particles correlates with nuclear factor kappaB (NF-kappaB) activation and increased rel A and NF-kappaB1 binding to the collagen promoter. J Bone Miner Res. 2001;16(3):501\u201310.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2260_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/mnfr.200900414","volume":"54","author":"CT Yeh","year":"2010","unstructured":"Yeh CT, Wu CH, Yen GC. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res. 2010;54(9):1285\u201395.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"2260_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.bbamcr.2011.12.010","volume":"1823","author":"JI Barrasa","year":"2012","unstructured":"Barrasa JI, Olmo N, Santiago-Gomez A, Lecona E, Anglard P, Turnay J, et al. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1\/Smad complexes in human colon adenocarcinoma cells. Biochim Biophys Acta. 2012;1823(2):570\u201381.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2260_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ijc.26049","volume":"130","author":"H Guan","year":"2012","unstructured":"Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J, et al. Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int J Cancer. 2012;130(3):593\u2013601.","journal-title":"Int J Cancer"},{"issue":"6","key":"2260_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-011-0882-3","volume":"122","author":"WR Yu","year":"2011","unstructured":"Yu WR, Fehlings MG. Fas\/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application. Acta Neuropathol. 2011;122(6):747\u201361.","journal-title":"Acta Neuropathol"},{"key":"2260_CR42","doi-asserted-by":"crossref","unstructured":"Cartwright T, Perkins ND, C LW. NFKB1: a suppressor of inflammation, ageing and cancer. FEBS J. 2016;283(10):1812\u201322.","DOI":"10.1111\/febs.13627"},{"issue":"11 Pt A","key":"2260_CR43","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.bbamcr.2017.05.010","volume":"1864","author":"B Fingleton","year":"2017","unstructured":"Fingleton B. Matrix metalloproteinases as regulators of inflammatory processes. Biochimica et Biophysica Acta (BBA). 2017;1864(11 Pt A):2036\u201342.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"2260_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-019-1391-x","volume":"10","author":"FJ Cubero","year":"2019","unstructured":"Cubero FJ, Woitok MM, Zoubek ME, de Bruin A, Hatting M, Trautwein C. Disruption of the FasL\/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease. Cell Death Dis. 2019;10(2):115.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2260_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108(3):787\u201399.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2260_CR46","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.ajpath.2020.02.013","volume":"190","author":"A Krishnan","year":"2020","unstructured":"Krishnan A, Katsumi T, Guicciardi ME, Azad AI, Ozturk NB, Trussoni CE, et al. Tumor necrosis factor-related apoptosis-inducing ligand receptor deficiency promotes the ductular reaction, macrophage accumulation, and hepatic fibrosis in the Abcb4(\u2212\/\u2212) mouse. Am J Pathol. 2020;190(6):1284\u201397.","journal-title":"Am J Pathol"},{"issue":"10","key":"2260_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-021-04165-x","volume":"12","author":"C Burgaletto","year":"2021","unstructured":"Burgaletto C, Platania CBM, Di Benedetto G, Munafo A, Giurdanella G, Federico C, et al. Targeting the miRNA-155\/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer\u2019s disease. Cell Death Dis. 2021;12(10):905.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2260_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","volume":"9","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Lan T, Wei Y, Wei X. CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12\u201327.","journal-title":"Genes Dis"},{"issue":"3","key":"2260_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.cr.7310149","volume":"17","author":"P Gallinari","year":"2007","unstructured":"Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkuhler C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 2007;17(3):195\u2013211.","journal-title":"Cell Res"},{"issue":"6","key":"2260_CR50","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.devcel.2010.10.015","volume":"19","author":"M LeBoeuf","year":"2010","unstructured":"LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, et al. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell. 2010;19(6):807\u201318.","journal-title":"Dev Cell"},{"issue":"5","key":"2260_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.552310","volume":"24","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 2010;24(5):455\u201369.","journal-title":"Genes Dev"},{"issue":"8","key":"2260_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010376","volume":"18","author":"L Hess","year":"2022","unstructured":"Hess L, Moos V, Lauber AA, Reiter W, Schuster M, Hartl N, et al. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation. PLoS Genet. 2022;18(8):e1010376.","journal-title":"PLoS Genet"},{"issue":"6","key":"2260_CR53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.cdd.4400851","volume":"8","author":"S Gobeil","year":"2001","unstructured":"Gobeil S, Boucher CC, Nadeau D, Poirier GG. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001;8(6):588\u201394.","journal-title":"Cell Death Differ"},{"issue":"7983","key":"2260_CR54","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli S, Salmonowicz H, Chapman J, Martini H, Vizioli MG, Riley JS, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature. 2023;622(7983):627\u201336.","journal-title":"Nature"},{"issue":"6","key":"2260_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7(6):11190.","journal-title":"Nat Commun"},{"issue":"9","key":"2260_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14229","volume":"23","author":"M Shen","year":"2024","unstructured":"Shen M, Fu J, Zhang Y, Chang Y, Li X, Cheng H, et al. A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX. Aging Cell. 2024;23(9):e14229.","journal-title":"Aging Cell"},{"issue":"12","key":"2260_CR57","doi-asserted-by":"publisher","first-page":"19074","DOI":"10.18632\/oncotarget.13572","volume":"8","author":"AH Nguyen","year":"2017","unstructured":"Nguyen AH, Elliott IA, Wu N, Matsumura C, Vogelauer M, Attar N, et al. Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Oncotarget. 2017;8(12):19074\u201388.","journal-title":"Oncotarget"},{"issue":"3","key":"2260_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1097-2765(04)00028-0","volume":"13","author":"C Yu","year":"2004","unstructured":"Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, et al. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell. 2004;13(3):329\u201340.","journal-title":"Mol Cell"},{"issue":"9\u201310","key":"2260_CR59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.18632\/genesandcancer.155","volume":"8","author":"DN Dhanasekaran","year":"2017","unstructured":"Dhanasekaran DN, Reddy EP. JNK-signaling: A multiplexing hub in programmed cell death. Genes Cancer. 2017;8(9\u201310):682\u201394.","journal-title":"Genes Cancer"},{"key":"2260_CR60","doi-asserted-by":"crossref","unstructured":"Chuang HC, Hsueh CH, Hsu PM, Tsai CY, Shih YC, Chiu HY, et al. DUSP8 induces TGF-beta-stimulated IL-9 transcription and Th9-mediated allergic inflammation by promoting nuclear export of Pur-alpha. J Clin Invest. 2023;133(21).","DOI":"10.1172\/JCI166269"},{"issue":"7","key":"2260_CR61","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/cells11071106","volume":"11","author":"V Kirsch","year":"2022","unstructured":"Kirsch V, Ramge JM, Schoppa A, Ignatius A, Riegger J. In vitro characterization of doxorubicin-mediated stress-induced premature senescence in human chondrocytes. Cells. 2022;11(7):1106.","journal-title":"Cells."},{"issue":"6","key":"2260_CR62","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1517\/13543784.2011.577737","volume":"20","author":"Y Boumber","year":"2011","unstructured":"Boumber Y, Younes A, Garcia-Manero G. Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor. Expert Opin Investig Drugs. 2011;20(6):823\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"2260_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2016.36","volume":"2","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Sun M, Zhou S, Guo B. Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6. Cell Death Discov. 2016;2:16036.","journal-title":"Cell Death Discov"},{"issue":"3","key":"2260_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cllc.2023.01.013","volume":"24","author":"ML Johnson","year":"2023","unstructured":"Johnson ML, Strauss J, Patel MR, Garon EB, Eaton KD, Neskorik T, et al. Mocetinostat in combination with durvalumab for patients with advanced NSCLC: results from a phase I\/II study. Clin Lung Cancer. 2023;24(3):218\u201327.","journal-title":"Clin Lung Cancer"},{"key":"2260_CR65","doi-asserted-by":"crossref","unstructured":"Khathayer F, Mikael M. Mocetinostat as a novel selective histone deacetylase (HDAC) inhibitor in the promotion of apoptosis in glioblastoma cell line C6 and T98G. Res Sq. [Preprint] 2024;rs.3.rs-4170668.","DOI":"10.21203\/rs.3.rs-4170668\/v1"},{"issue":"5","key":"2260_CR66","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","volume":"60","author":"D Kim","year":"2008","unstructured":"Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, et al. Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity. Neuron. 2008;60(5):803\u201317.","journal-title":"Neuron"},{"issue":"4","key":"2260_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.exger.2009.10.001","volume":"45","author":"D Willis-Martinez","year":"2010","unstructured":"Willis-Martinez D, Richards HW, Timchenko NA, Medrano EE. Role of HDAC1 in senescence, aging, and cancer. Exp Gerontol. 2010;45(4):279\u201385.","journal-title":"Exp Gerontol"},{"issue":"5","key":"2260_CR68","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/1535-7163.MCT-09-1000","volume":"9","author":"V El-Khoury","year":"2010","unstructured":"El-Khoury V, Moussay E, Janji B, Palissot V, Aouali N, Brons NH, et al. The histone deacetylase inhibitor MGCD0103 induces apoptosis in B-cell chronic lymphocytic leukemia cells through a mitochondria-mediated caspase activation cascade. Mol Cancer Ther. 2010;9(5):1349\u201360.","journal-title":"Mol Cancer Ther"},{"key":"2260_CR69","doi-asserted-by":"crossref","unstructured":"Tammaro A, Daniels EG, Hu IM, t Hart KC, Reid K, Juni RP, et al. HDAC1\/2 inhibitor therapy improves multiple organ systems in aged mice. iScience. 2024;27(1):108681.","DOI":"10.1016\/j.isci.2023.108681"},{"issue":"11","key":"2260_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009;32(11):591\u2013601.","journal-title":"Trends Neurosci"},{"key":"2260_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mod.2016.07.001","volume":"141","author":"T Zhang","year":"2016","unstructured":"Zhang T, Sheng Z, Du W. Loss of histone deacetylase HDAC1 induces cell death in Drosophila epithelial cells through JNK and Hippo signaling. Mech Dev. 2016;141:4\u201313.","journal-title":"Mech Dev"},{"key":"2260_CR72","doi-asserted-by":"crossref","unstructured":"Watson PJ, Millard CJ, Celardo I, Gordiyenko Y, Cowley SM, Robinson CV, Fairall L, Schwabe JW. Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates. Mol Cell. 2013;51(1):57\u201367.","DOI":"10.1016\/j.molcel.2013.05.020"},{"issue":"4","key":"2260_CR73","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI16153","volume":"111","author":"N Mishra","year":"2003","unstructured":"Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse. J Clin Invest. 2003;111(4):539\u201352.","journal-title":"J Clin Invest"},{"issue":"8","key":"2260_CR74","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/rheumatology\/keq108","volume":"49","author":"QY Choo","year":"2010","unstructured":"Choo QY, Ho PC, Tanaka Y, Lin HS. Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology (Oxford). 2010;49(8):1447\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2260_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245169","volume":"16","author":"BA Stanfield","year":"2021","unstructured":"Stanfield BA, Purves T, Palmer S, Sullenger B, Welty-Wolf K, Haines K, et al. IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages. PLoS One. 2021;16(1):e0245169.","journal-title":"PLoS One"},{"key":"2260_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104799","volume":"19;25(8)","author":"JD Moreira","year":"2022","unstructured":"Moreira JD, Iakhiaev A, Vankayalapati R, Jung BG, Samten B. Histone deacetylase-2 controls IL-1beta production through the regulation of NLRP3 expression and activation in tuberculosis infection. iScience. 2022;25(8):104799.","journal-title":"iScience"},{"key":"2260_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074031","author":"DA Bogdanova","year":"2024","unstructured":"Bogdanova DA, Kolosova ED, Pukhalskaia TV, Levchuk KA, Demidov ON, Belotserkovskaya EV. The differential effect of senolytics on SASP cytokine secretion and regulation of EMT by CAFs. Int J Mol Sci. 2024;25(7):4031.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2260_CR78","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1038\/sj.cdd.4401915","volume":"13","author":"YK Kim","year":"2006","unstructured":"Kim YK, Lee EK, Kang JK, Kim JA, You JS, Park JH. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis. Cell Death Differ. 2006;13(12):2033\u201341.","journal-title":"Cell Death Differ"},{"key":"2260_CR79","doi-asserted-by":"crossref","unstructured":"Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065\u201377.","DOI":"10.1128\/MCB.21.20.7065-7077.2001"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02260-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:02:53Z","timestamp":1777158173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02260-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":79,"alternative-id":["2260"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02260-5","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}